Market Analysts see Vaxart Inc. [VXRT] falling to $12. Time to buy?

Vaxart Inc. [NASDAQ: VXRT] traded at a low on 08/25/22, posting a -5.35 loss after which it closed the day’ session at $3.36. The company report on August 25, 2022 that Vaxart Announces Highly Regarded Biotech Executive Elaine J. Heron, Ph.D. Joins Board of Directors.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Dr. Heron brings decades of experience in executive leadership and life sciences research and development to Vaxart’s Board.

Vaxart, Inc. (NASDAQ: VXRT) today announced that Elaine J. Heron, Ph.D. was appointed to the Company’s Board of Directors, effective August 25, 2022.

The results of the trading session contributed to over 1911265 shares changing hands. Over the past one week, the price volatility of Vaxart Inc. stands at 7.70% while the volatility over the past one month is 7.28%.

The market cap for VXRT stock reached $451.82 million, with 126.43 million shares outstanding and 125.42 million shares in the current float. Compared to the average trading volume of 2.57M shares, VXRT reached a trading volume of 1911265 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Vaxart Inc. [VXRT]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VXRT shares is $8.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VXRT stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Jefferies have made an estimate for Vaxart Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 29, 2021. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Overweight. The new note on the price target was released on November 02, 2021, representing the official price target for Vaxart Inc. stock. Previously, the target price had yet another drop from $13 to $9, while B. Riley Securities kept a Neutral rating on VXRT stock.

The Average True Range (ATR) for Vaxart Inc. is set at 0.28, with the Price to Sales ratio for VXRT stock in the period of the last 12 months amounting to 1129.55. The Price to Book ratio for the last quarter was 2.97, with the Price to Cash per share for the same quarter was set at 0.96.

How has VXRT stock performed recently?

Vaxart Inc. [VXRT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -13.40. With this latest performance, VXRT shares dropped by -11.58% in over the last four-week period, additionally sinking by -33.86% over the last 6 months – not to mention a drop of -63.52% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VXRT stock in for the last two-week period is set at 38.29, with the RSI for the last a single of trading hit 32.64, and the three-weeks RSI is set at 41.97 for Vaxart Inc. [VXRT]. The present Moving Average for the last 50 days of trading for this stock 3.85, while it was recorded at 3.49 for the last single week of trading, and 4.75 for the last 200 days.

Vaxart Inc. [VXRT]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Vaxart Inc. [VXRT] shares currently have an operating margin of -7819.17. Vaxart Inc.’s Net Margin is presently recorded at -7900.22.

Return on Equity for this stock declined to -45.33, with Return on Assets sitting at -37.71.

Vaxart Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 8.70 and a Current Ratio set at 8.70.

Insider trade positions for Vaxart Inc. [VXRT]

There are presently around $149 million, or 36.00% of VXRT stock, in the hands of institutional investors. The top three institutional holders of VXRT stocks are: STATE STREET CORP with ownership of 12,671,950, which is approximately -8.578% of the company’s market cap and around 0.90% of the total institutional ownership; BLACKROCK INC., holding 9,184,233 shares of the stock with an approximate value of $30.86 million in VXRT stocks shares; and VANGUARD GROUP INC, currently with $22.33 million in VXRT stock with ownership of nearly 9.394% of the company’s market capitalization.

Positions in Vaxart Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 57 institutional holders increased their position in Vaxart Inc. [NASDAQ:VXRT] by around 4,008,232 shares. Additionally, 69 investors decreased positions by around 4,650,513 shares, while 39 investors held positions by with 35,792,900 shares. The mentioned changes placed institutional holdings at 44,451,645 shares, according to the latest SEC report filing. VXRT stock had 19 new institutional investments in for a total of 809,410 shares, while 24 institutional investors sold positions of 316,821 shares during the same period.


Please enter your comment!
Please enter your name here